bullish
Acadia Pharma: Hedge Fund Favorite and Upcoming Catalyst.
519 Views09 Dec 2016 05:51
We took another look at P2 trial design for Acadia Pharmaceuticals Inc (ACAD US) Alzheimer's disease Psychosis ADP trial (results expected later...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 2-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Standing Alone in the Ampakines Pipeline: Biogen Sees Potential in Pfizer's Neuropsychiatry Asset15 Mar 2018
- New Long Position: Novel Drug for Wet-AMD, a Common Cause of Blindness, and Upcoming Catalyst.06 Dec 2016
- New Long Position: Gene Therapy for Parkinson's Disease and Upcoming Catalysts05 Dec 2016
x